1007 Voclosporin for lupus nephritis: assessment of long-term safety and efficacy including renal outcome over three years of treatment in the phase 3 AURORA 1 and AURORA 2 studies

• Cristina Arriens,
• Samir V Parikh,
• Christopher M Mela,
• Henry Leher,
• Lucy Hodge

Affiliations

Cristina Arriens

1Oklahoma Medical Research Foundation, Oklahoma City, United States of America

Samir V Parikh

2The Ohio State University Wexner Medical Center, Columbus

Christopher M Mela

3Aurinia Pharmaceuticals Inc., Edmonton AB, Canada

Henry Leher

2Aurinia Pharmaceuticals Inc., Victoria, Canada

Lucy Hodge

2Dept. of Medicine, Columbia University Medical Center, New York, USA